66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Friendship Meeting mit der Italienischen Gesellschaft für Neurochirurgie (SINch)
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
7. - 10. Juni 2015, Karlsruhe
Vorträge Mittwoch, 10. Juni 2015
MI.16 Freie Themen 21: Tumore allgemein 2
Meeting Abstract
(MI.16.01)
[Volltext]
Can early postoperative FET-PET predict the location of GBM recurrence after resection?
Buchmann N, Gempt J, Ryang YM, Meyer B, Ringel F[Volltext]
Meeting Abstract
(MI.16.02)
[Volltext]
Use of 5-ALA as a surgical tool for recurrent glioblastoma
Quick-Weller J, Konczalla J, Lescher S, Forster MT, Seifert V, Senft C[Volltext]
Meeting Abstract
(MI.16.03)
[Volltext]
Dynamic 18FET-PET predicts the outcome in anaplastic glioma WHO° III and is correlated with IDH 1 mutation status
Suchorska B, Jansen N, Kraus T, Giese A, Bartenstein P, Tonn JC[Volltext]
Meeting Abstract
(MI.16.04)
[Volltext]
Growth dynamic of untreated glioblastoma multiforme
Rueß D, Blau T, Wipplinger C, Koller L, Treuer H, Ruge MI[Volltext]
Meeting Abstract
(MI.16.05)
[Volltext]
Growth dynamics of intracranial tumors in patients suffering from Neurofibromatosis type 2
McLean AL, Rosahl S[Volltext]
Meeting Abstract
(MI.16.06)
[Volltext]
Growth dynamics of intramedullary spinal tumors in patients suffering from Neurofibromatosis type 2
McLean AL, Rosahl S[Volltext]
Meeting Abstract
(MI.16.07)
[Volltext]
Identification of supportive care needs in patients with high-grade gliomas using the SCNS-SF34-G questionnaire – “mission impossible”? Results of the prospective multicentric trial “ERASMUS” of 175 patients
Renovanz M, Hechtner M, Hickmann AK, Singer S, Coburger J, Giese A[Volltext]
Meeting Abstract
(MI.16.08)
[Volltext]
MRI findings in TERT mutated and MGMT hypermethylated primary glioblastomas
Ersoy TF, Keil V, Schild HH, Waha A, Kumar R, Simon M[Volltext]
Meeting Abstract
(MI.16.09)
[Volltext]
Surgical vs. conservative therapy of glioblastoma multiforme in patients aged ≥75 years
Kunze F, Franz K, Gessler F, Harter PN, Seifert V, Senft C[Volltext]
Meeting Abstract
(MI.16.10)
[Volltext]
Assessment of treatment response in an orthotopic IDH1-mutant glioma model using in-vivo magnetic resonance spectroscopy – a feasibility study
Loebel F, Tateishi K, Huber P, Wakimoto H, Chi AS, Cahill DP, Andronesi OC[Volltext]
Meeting Abstract
(MI.16.11)
[Volltext]
Cognitive function of patients with neuroepithelial brain tumors
Gempt J, Järschke J, Ryang YM, Schirmer L, Meyer B, Ringel F[Volltext]
Meeting Abstract
(MI.16.12)
[Volltext]
Is it “enough” to assess quality of life in a neurooncological patient? Association between health-related quality of life (HRQoL), psychosocial distress and supportive care needs in patients with malignant brain tumors: A prospective multicenter analysis of 175 patients with malignant gliomas in an outpatient setting
Hickmann AK, Hechtner M, Renovanz M, Nadji-Ohl M, König J, Coburger J[Volltext]
